STAND-BY PURCHASE AGREEMENTStand-by Purchase Agreement • September 2nd, 2005 • Biotime Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledSeptember 2nd, 2005 Company Industry JurisdictionBioTime, Inc., a California corporation (the “Company”) and each of the persons named on Schedule I (the “Guarantors”) hereby agree as follows:
Amendment of Warrant Agreement Dated as of , 2005Warrant Agreement • September 2nd, 2005 • Biotime Inc • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 2nd, 2005 Company IndustryTHIS AMENDMENT OF WARRANT AGREEMENT, dated as of , 2005, between BioTime, Inc., a California corporation (the “Company”), and American Stock Transfer & Trust Company (“Warrant Agent”) for the benefit of each registered holder of a Warrant described herein (“Holder”) amends that certain Warrant Agreement dated December 9, 2003 (the “Agreement”). The Company has previously issued 2,780,150 common share purchase warrants (the “Original Warrants”) governed by the Agreement. The Company proposes to issue additional common share purchase warrants (the “Additional Warrants”) to purchase up to an aggregate of 5,961,435 of its common shares, no par value (the “Common Stock”) as follows: (a) up to 3,574,290 upon the exercise of subscription rights (the “Rights”); (b) up to an additional 1,787,145 Warrants through the sale of up to 1,787,145 Units to fill excess over-subscriptions of Rights, and (c) 600,000 Warrants to certain persons named as Guarantors pursuant to a Standby Purchase Agreement b